PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global pharmaceutical stability and storage services market is estimated to be valued at USD 3.18 Bn in 2024 and is expected to reach USD 4.71 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Global pharmaceutical stability and storage services market has been growing steadily over the past few years. Pharmaceutical products need to maintain their efficacy, safety, and quality over their shelf life. Stability testing helps to determine a drug's expiration date and ensures it meets all regulatory standards throughout its approved shelf life. Various factors like temperature, humidity, and light exposure can degrade pharmaceuticals over time. Stability testing determines the impact of external influences on drug deterioration and generates the data required to assign optimal storage conditions and expiration dates. It is crucial for developing robust packaging and maximizing a drug's shelf life and is mandated by regulatory bodies. The demand for such services is expected to increase with novel drug approvals and growing generics market worldwide.

Market Dynamics:

Global pharmaceutical stability and storage services market growth is driven by factors such as rising pharmaceutical R&D expenditure, stringent regulatory compliance for drug approval, increasing generics market, and growing demand for outsourcing of related services. However, high costs associated with these specialized testing services and lack of harmonization in global regulations continue to restrain the market growth. Emerging markets such as the Asia Pacific and Latin America offer lucrative opportunities for leading service providers to expand their geographic footprint. Furthermore, increasing demand for specialized services like accelerated stability testing and cold chain logistics worldwide will likely open up new opportunities in the near future.

Key Features of the Study:

• This report provides an in-depth analysis of the global pharmaceutical stability and storage services market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pharmaceutical stability and storage services market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include Intertek Group plc, Eurofins Scientific, SGS Société Générale de Surveillance SA., Q Laboratories, BioLife Solutions Inc., Cencora, Inc., Alloga, PCI Pharma Services, Pharmaserv GmbH, Catalent, Inc, Almac Group, Charles River Laboratories, Lucideon, Alcami Corporation, Element Materials Technology, Nelson Laboratories, LLC, and ALS.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global pharmaceutical stability and storage services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical stability and storage services market.

Detailed Segmentation:

• Service Type:
  • Stability
    • Accelerated Stability Testing
    • Photostability
    • Long Term Drug Stability Testing
    • Forced Degradation Testing
    • Others
  • Storage
    • Cold Storage
      • Controlled 15-25°C
      • Refrigerated 2-8°C
      • Frozen -24°C
      • Cryogenic -170°C
    • Non - Cold Storage
•  Product Type:
  • Tablets
  • Capsules
  • Injectable Solutions
  • Oral Suspensions
  • Combination Products
  • Others
• End User:
  • Biopharmaceutical Companies
  • CMO
  • CRO
  • Others
• Region: 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Intertek Group plc
  • Eurofins Scientific 
  • SGS Société Générale de Surveillance SA.
  • Q Laboratories
  • BioLife Solutions Inc.
  • Cencora, Inc.
  • Alloga 
  • PCI Pharma Services
  • Pharmaserv GmbH
  • Catalent, Inc
  • Almac Group
  • Charles River Laboratories
  • Lucideon
  • Alcami Corporation
  • Element Materials Technology
  • Nelson Laboratories, LLC
  • ALS